Skip to content
10-Q

Quarterly Report

Avant Diagnostics, Inc

0001493152-18-014808

← back to feed
Filed
Oct 23, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Sep 10, 2018 336.96M sh
Stockholders Equity Q2 2017 · Mar 31, 2017 $1.88M
Stockholders Equity Q2 2017 · Sep 30, 2016 $3.56M
Current Liabilities Q2 2017 · Mar 31, 2017 $3.82M
Current Liabilities Q2 2017 · Sep 30, 2016 $2.12M
Total Liabilities Q2 2017 · Mar 31, 2017 $3.82M
Total Liabilities Q2 2017 · Sep 30, 2016 $2.12M
Current Assets Q2 2017 · Mar 31, 2017 $45.88K
Current Assets Q2 2017 · Sep 30, 2016 $42.23K
Total Assets Q2 2017 · Mar 31, 2017 $5.7M
Total Assets Q2 2017 · Sep 30, 2016 $5.68M
Operating Cash Flow Q2 2017 · Mar 31, 2016 −$189.3K
Cash And Equivalents Q2 2017 · Mar 31, 2016 $215.16K
Cash And Equivalents Q2 2017 · Sep 30, 2015 $43.64K
Sga Expense Q2 2017 · Mar 31, 2016 $174.93K
Sga Expense Q2 2017 · Mar 31, 2016 $305.31K
Net Income Q2 2017 · Mar 31, 2016 −$234.75K
Net Income Q2 2017 · Mar 31, 2016 −$432.29K
Operating Income Q2 2017 · Mar 31, 2016 −$226.03K
Operating Income Q2 2017 · Mar 31, 2016 −$423.56K